All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is ...

Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

Kenvue stock surged Monday after the company — known for brands like Tylenol — announced sweeping changes, including naming a new CEO.

Musk has signaled that Tesla investors could vote on whether to invest in xAI at the upcoming shareholder meeting. Kenvue (KVUE) CEO is stepping down as pressure from activist investors intensifies.

Kenvue (KVUE +1%) is ticking higher following a flurry of announcements this morning. The company, which provides consumer health products across self-care and essential health categories (Tylenol, ...

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and r ...

Activist shareholders are poised to push harder for corporate changes in the coming months, finding fresh confidence to launch campaigns as the pace of dealmaking picks up again.

Activist investors who push companies for operational changes and management shake-ups waged fewer campaigns during the first half of 2025 as tariffs, wars and U.S. President Donald Trump's ...